GH Research PLC

General ticker "GHRS" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $433.9M

GH Research PLC follows the US Stock Market performance with the rate: 8.1%.

Estimated limits based on current volatility of 4.9%: low 6.81$, high 7.52$

Factors to consider:

  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.28$, 7.50$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.30$, 7.17$]

Financial Metrics affecting the GHRS estimates:

  • Negative: Non-GAAP EPS, $ of -0.68 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -9.76 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term GHRS quotes

Long-term GHRS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $15.10MM $30.55MM $41.22MM
Operating Income $-15.10MM $-30.55MM $-41.22MM
Non-Operating Income $5.90MM $8.10MM $5.63MM
Interest Expense $0.01MM $0.00MM $0.72MM
R&D Expense $8.55MM $20.48MM $29.79MM
Income(Loss) $-9.20MM $-22.46MM $-35.59MM
Taxes $0.01MM $-15.32MM $0.00MM
Profit(Loss) $-9.21MM $-7.13MM $-35.59MM
Stockholders Equity $277.18MM $249.82MM $218.97MM
Inventory $3.01MM $0.09MM $0.00MM
Assets $279.92MM $254.36MM $226.30MM
Operating Cash Flow $-15.28MM $-26.20MM $-33.34MM
Capital expenditure $0.10MM $0.07MM $0.10MM
Investing Cash Flow $-0.10MM $-84.69MM $-54.10MM
Financing Cash Flow $286.45MM $0.00MM $-0.20MM
Earnings Per Share* $-0.18 $-0.14 $-0.68

* EPS are Split Adjusted, recent splits may be reflected with a delay.